| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
insulin receptor substrate 2 | 0.535 | 0.654 | 0.99 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
phenotype | 0.240 | None | 1.000 | 1 | 0 | 2012 | 2019 | ||||||||
|
adiponectin receptor 2 | 0.564 | 0.731 | 0.36 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 0.482 | 0.846 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1985 | 1985 | ||||||||
|
trefoil factor 3 | 0.518 | 0.885 | 1.6E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
steroidogenic acute regulatory protein | 0.513 | 0.808 | 8.8E-11 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
sterol regulatory element binding transcription factor 1 | 0.518 | 0.808 | 1.5E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
bone morphogenetic protein 4 | 0.422 | 0.808 | 0.96 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
solute carrier family 2 member 3 | 0.534 | 0.769 | 1.0E-02 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2001 | 2013 | ||||||||
|
solute carrier family 2 member 2 | 0.572 | 0.692 | 3.4E-08 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.280 | None | 1.000 | 1 | 0 | 2012 | 2020 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
phenotype | 0.220 | None | 1.000 | 1 | 0 | 2011 | 2013 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.230 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
prostaglandin E receptor 3 | 0.601 | 0.731 | 0.37 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
phenotype | 0.240 | None | 1.000 | 1 | 0 | 2013 | 2018 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
phenotype | 0.240 | None | 1.000 | 1 | 0 | 2012 | 2019 | ||||||||
|
mucin 4, cell surface associated | 0.506 | 0.769 | 2.8E-54 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
SIN3 transcription regulator family member A | 0.551 | 0.692 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
unc-13 homolog A | 0.705 | 0.423 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
angiotensin II receptor type 2 | 0.496 | 0.808 | 8.2E-03 |
|
phenotype | 0.220 | None | 1.000 | 1 | 0 | 2006 | 2018 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
phenotype | 0.250 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
dual specificity phosphatase 5 | 0.597 | 0.654 | 3.3E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
dual specificity phosphatase 1 | 0.491 | 0.808 | 1.0E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
phenotype | 0.600 | None | 1.000 | 1 | 0 | 1998 | 2019 |